Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
Add more filters










Publication year range
1.
Parasitol Int ; 76: 102065, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32001348

ABSTRACT

Trypanosoma cruzi, the causative agent of Chagas disease, and Toxoplasma gondii, which is responsible for Toxoplasmosis, are two parasites that cause significant protozoan zoonoses and consequently important economic losses in human, companion animals and livestock. For the congenital transmission to occur, both parasites must cross the barrier present in the mammalian placenta, which differs between species. Particularly, hemochorial, endotheliochorial and epitheliochorial placental barriers are present, respectively, in human, dog and sheep. The type of placental barrier has been associated with the probability of transmission of pathogens. In this study, we used experimental placental ex vivo infection models of T. cruzi and T. gondii in the above-mentioned mammals in order to study tissue alterations and to compare infection efficiency. Here, we infected placental term explants from human, dog and sheep and analyzed tissue damage by standard histological and histochemical methods. Comparative infection efficiency was determined by quantitative PCR. Both parasites are able to infect the different placental explants; however, more T. gondii parasites were detected, and T. gondii causes a more severe tissue damage in human and canine explants than T. cruzi. The histopathological changes observed in ovine placenta explants were similar in presence of both parasites. We conclude that the infection efficiency of T. gondii is higher, compared to T. cruzi, during the ex vivo infection of human, canine and ovine placental explants. In addition, the ex vivo infection of mammalian placental explants constitutes an interesting experimental approach to study part of the infection mechanisms as well as host responses during congenital infection of both parasites.


Subject(s)
Chagas Disease/pathology , Placenta/pathology , Placenta/parasitology , Toxoplasmosis, Animal/pathology , Toxoplasmosis/pathology , Animals , Chagas Disease/veterinary , Dogs/parasitology , Female , Humans , In Vitro Techniques , Pregnancy , Sheep/parasitology , Toxoplasma/pathogenicity , Trypanosoma cruzi/pathogenicity
2.
J Cell Biochem ; 120(10): 16733-16740, 2019 10.
Article in English | MEDLINE | ID: mdl-31099049

ABSTRACT

Trypanosoma cruzi is under the attack of reactive species produced by its mammalian and insect hosts. To survive, it must repair its damaged DNA. We have shown that a base excision DNA repair (BER)-specific parasite TcAP1 endonuclease is involved in the resistance to H2 O2 . However, a putative TcAP1 negative dominant form impairing TcAP1 activity in vitro did not show any in vivo effect. Here, we show that a negative dominant form of the human APE1 apurinic/apyrimidinic (AP) endonuclease (hAPE1DN) induces a decrease in epimastigote and metacyclic trypomastigote viability when parasites were exposed to H2 O2 . Those results confirm that TcAP1 AP endonuclease activity plays an important role in epimastigote and in infective metacyclic trypomastigote oxidative DNA damage resistance leading to parasite persistence in the insect and mammalian hosts. All along its biological cycle and in its different cellular forms, T. cruzi, the etiological parasite agent of Chagas' disease, is under the attack of reactive species produced by its mammalian and insect hosts. To survive, T. cruzi must repair their oxidative damaged DNA. We have previously shown that a specific parasite TcAP1 AP endonuclease of the BER is involved in the T. cruzi resistance to oxidative DNA damage. We have also demonstrated that epimastigotes and cell-derived trypomastigotes parasite forms expressing a putative TcAP1 negative dominant form (that impairs the TcAP1 activity in vitro), did not show any in vivo effect in parasite viability when exposed to oxidative stress. In this work, we show the expression of a negative dominant form of the human APE1 AP endonuclease fused to a green fluorescent protein (GFP; hAPE1DN-GFP) in T. cruzi epimastigotes. The fusion protein is found both in the nucleus and cytoplasm of noninfective epimastigotes but only in the nucleus in metacyclic and cell-derived trypomastigote infective forms. Contrarily to the TcAP1 negative dominant form, the ectopic expression of hAPE1DN-GFP induces a decrease in epimastigote and metacyclic trypomastigote viability when parasites were exposed to increasing H2 O2 concentrations. No such effect was evident in expressing hAPE1DN-GFP cell-derived trypomastigotes. Although the viability of both wild-type infective trypomastigote forms diminishes when parasites are submitted to acute oxidative stress, the metacyclic forms are more resistant to H2 O2 exposure than cell-derived trypomastigotes.Those results confirm that the BER pathway and particularly the AP endonuclease activity play an important role in epimastigote and metacyclic trypomastigote oxidative DNA damage resistance leading to parasite survival and persistence inside the mammalian and insect host cells.


Subject(s)
DNA Damage , DNA Repair , Oxidative Stress , Protozoan Proteins/metabolism , Trypanosoma cruzi/enzymology , DNA-(Apurinic or Apyrimidinic Site) Lyase/genetics , Genes, Dominant , Humans , Hydrogen Peroxide/pharmacology , Microorganisms, Genetically-Modified , Protozoan Proteins/genetics , Trypanosoma cruzi/genetics
3.
PLoS One ; 14(1): e0211542, 2019.
Article in English | MEDLINE | ID: mdl-30699191

ABSTRACT

BACKGROUND: Cystic echinococcosis is caused by the metacestode of the zoonotic flatworm Echinococcus granulosus. Within the viscera of the intermediate host, the metacestode grows as a unilocular cyst known as hydatid cyst. This cyst is comprised of two layers of parasite origin: germinal and laminated layers, and one of host origin: the adventitial layer, that encapsulates the parasite. This adventitial layer is composed of collagen fibers, epithelioid cells, eosinophils and lymphocytes. To establish itself inside the host, the germinal layer produces the laminated layer, and to continue its life cycle, generates protoscoleces. Some cysts are unable to produce protoscoleces, and are defined as infertile cysts. The molecular mechanisms involved in cyst fertility are not clear, however, the host immune response could play a crucial role. METHODOLOGY/PRINCIPAL FINDINGS: We collected hydatid cysts from both liver and lungs of slaughtered cattle, and histological sections of fertile, infertile and small hydatid cysts were stained with haematoxylin-eosin. A common feature observed in infertile cysts was the disorganization of the laminated layer by the infiltration of host immune cells. These infiltrating cells eventually destroy parts of laminated layer. Immunohistochemical analysis of both parasite and host antigens, identify these cells as cattle macrophages and are present inside the cysts associated to germinal layer. CONCLUSIONS/SIGNIFICANCE: This is the first report that indicates to cell from immune system present in adventitial layer of infertile bovine hydatid cysts could disrupt the laminated layer, infiltrating and probably causing the infertility of cyst.


Subject(s)
Cattle Diseases/immunology , Echinococcosis/immunology , Echinococcosis/veterinary , Echinococcus granulosus/immunology , Fertility/immunology , Infertility/immunology , Animals , Cattle , Cattle Diseases/parasitology , Echinococcosis/parasitology , Echinococcus granulosus/pathogenicity , Infertility/parasitology , Liver/immunology , Liver/parasitology , Lung/immunology , Lung/parasitology
4.
Acta Trop ; 186: 35-40, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30018029

ABSTRACT

Congenital Chagas disease, caused by Trypanosoma cruzi (T. cruzi), has become epidemiologically relevant. The probability of congenital transmission depends on the maternal and developing fetal/newborn immune responses, placental factors and importantly, the virulence of the parasite. It has been proposed, that different genotypes of T. cruzi and their associated pathogenicity, virulence and tissue tropism may play an important role in congenital infection. Since there is no laboratory or animal model that recapitulates the complexities of vertical transmission in humans, here we studied parasite infectivity in human placental explants (HPE) as well as in the human trophoblast-derived cell line BeWo of the Y(DTU II) and the VD (TcVI) T. cruzi strains; the latter was isolated from a human case of congenital infection. Our results show that the VD strain is more infective and pathogenic than the Y strain, as demonstrated by qPCR and cell counting as well as by histopathological analysis. The present study constitutes the first approach to study the relationship between parasite two parasite strains from different genotypes and the infection efficiency in human placenta.


Subject(s)
Chagas Disease/transmission , Host-Parasite Interactions/physiology , Placenta/parasitology , Pregnancy Complications, Infectious/parasitology , Trypanosoma cruzi/physiology , Animals , Cell Line , Chagas Disease/congenital , Female , Fetus , Humans , Infectious Disease Transmission, Vertical , Placenta/immunology , Pregnancy , Pregnancy Complications, Infectious/immunology , Trypanosoma cruzi/cytology
5.
J Cell Biochem ; 119(7): 5985-5995, 2018 07.
Article in English | MEDLINE | ID: mdl-29575156

ABSTRACT

Trypanosoma cruzi, the causative agent of Chagas' disease survives to DNA damage generated by ROS/RNS inside to their different hosts. In recent eukaryotes, oxidative DNA damage is repaired mainly by the Base Excision Repair (BER) pathway, being essential the apurinic/apyrimidinic endonuclease activity. Using a pTREX-gfp vector, the nucleotide sequence that encodes T. cruzi AP endonuclease TcAP1 (orthologue of human APE1) and a putative TcAP1 dominant negative (TcAP1DN), were transfectedand expressed in T. cruzi epimastigotes. TcAP1-GFP and TcAP1DN-GFP were expressed in those modified epimastigotes and found in the parasite nucleus. The endonucleases were purified under native conditions and the AP endonuclease activity was evaluated. While TcAP1 presents the expected AP endonuclease activity TcAP1DN does not. Moreover, TcAP1DN partially inhibits in vitro TcAP1 enzymatic activity. Transfected epimastigotes expressing TcAP1-GFP and TcAP1DN-GFP were differentiated to infective trypomastigotes. The infective parasites maintained both proteins (TcAP1-GFP and TcAP1DN-GFP) in the nucleus. The overexpression of TcAP1-GFP in epimastigotes and trypomastigotes increases the viability of both parasite forms when exposed to oxidative stress while the expression of TcAP1DN-GFP did not show any in vivo inhibitory effect, suggesting that endogenous TcAP1 constitutive expression overcomes the TcAP1DN inhibitory activity. Our results show that TcAP1 is important for trypomastigote survival under oxidative conditions similar to those found in infected mammalian cells, then increasing its permanence in the infected cells and the possibility of development of Chagas disease.


Subject(s)
Chagas Disease/pathology , DNA Damage , DNA-(Apurinic or Apyrimidinic Site) Lyase/metabolism , Oxidative Stress , Protozoan Proteins/metabolism , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/metabolism , Amino Acid Sequence , Chagas Disease/genetics , Chagas Disease/parasitology , DNA Repair , DNA-(Apurinic or Apyrimidinic Site) Lyase/genetics , Humans , Life Cycle Stages , Mutation , Oxidation-Reduction , Protozoan Proteins/genetics , Sequence Homology , Trypanosoma cruzi/genetics
6.
Placenta ; 60: 40-46, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29208238

ABSTRACT

BACKGROUND: Congenital Chagas disease is caused by the protozoan parasite Trypanosoma cruzi that must cross the placental barrier during transmission. The trophoblast constitutes the first tissue in contact with the maternal-blood circulating parasite. Importantly, the congenital transmission rates are low, suggesting the presence of local placental defense mechanisms. On the other hand, the placenta is considered an immune regulatory organ since it acts as a modulator of fetal and maternal immune responses. We have previously proposed that local placental factors, such as the epithelial turnover of the trophoblast and the innate immune response initiated by Toll-like receptors (TLRs), might prevent parasite infection and congenital transmission. Here, we studied in an ex vivo infected human placental chorionic villi explant HPCVE model, the relationship between TLR-2 activation in response to T. cruzi trypomastigotes, the secreted profile of cytokines, the integrity of the placental barrier and the expression of trophoblast turnover markers. RESULTS: TLR-2 inhibition increases the parasite induced histopathological damage, prevents secretion of IL-6 and IL-10, decreases expression of PCNA (proliferation marker) and of ß-hCG (differentiation marker) while increasing caspase 3 activity (cell death marker). CONCLUSION: Our results suggest that TLR-2 is not only involved in the local secretion of cytokines but also regulates, at least partially, the trophoblast turnover.


Subject(s)
Chagas Disease/immunology , Placenta/immunology , Pregnancy Complications, Infectious/immunology , Toll-Like Receptor 2/physiology , Animals , Chlorocebus aethiops , Cytokines/metabolism , Female , Humans , Immunity, Innate , Placenta/metabolism , Pregnancy , Trypanosoma cruzi , Vero Cells
7.
Infect Genet Evol ; 55: 332-342, 2017 11.
Article in English | MEDLINE | ID: mdl-28970112

ABSTRACT

Trypanosoma cruzi is a protozoan parasite and the causative agent of Chagas disease. Like most living organisms, it is susceptible to oxidative stress, and must adapt to distinct environments. Hence, DNA repair is essential for its survival and the persistence of infection. Therefore, we studied whether T. cruzi has a homolog counterpart of the MutY enzyme (TcMYH), important in the DNA Base Excision Repair (BER) mechanism. Analysis of T. cruzi genome database showed that this parasite has a putative MutY DNA glycosylase sequence. We performed heterologous complementation assays using this genomic sequence. TcMYH complemented the Escherichia coli MutY- strain, reducing the mutation rate to a level similar to wild type. In in vitro assays, TcMYH was able to remove an adenine that was opposite to 8-oxoguanine. We have also constructed a T. cruzi lineage that overexpresses MYH. Although in standard conditions this lineage has similar growth to control cells, the overexpressor is more sensitive to hydrogen peroxide and glucose oxidase than the control, probably due to accumulation of AP sites in its DNA. Localization experiments with GFP-fused TcMYH showed this enzyme is present in both nucleus and mitochondrion. QPCR and MtOX results reinforce the presence and function of TcMYH in these two organelles. Our data suggest T. cruzi has a functional MYH DNA glycosylase, which participates in nuclear and mitochondrial DNA Base Excision Repair.


Subject(s)
DNA Glycosylases/genetics , DNA Glycosylases/metabolism , Oxidative Stress , Trypanosoma cruzi/genetics , Trypanosoma cruzi/metabolism , Amino Acid Sequence , DNA Damage , DNA Glycosylases/chemistry , DNA Repair , DNA, Mitochondrial , Enzyme Activation , Glucose Oxidase/metabolism , Hydrogen Peroxide/metabolism , Mutation , Protein Transport , Sequence Analysis, DNA
8.
Am J Reprod Immunol ; 78(1)2017 07.
Article in English | MEDLINE | ID: mdl-28328108

ABSTRACT

PROBLEM: Trypanosoma cruzi and Toxoplasma gondii present, respectively, low and high congenital transmission rates. The placenta as an immune regulatory organ expresses TLRs, leading to the secretion of cytokines. Both parasites are recognized by TLR-2, TLR-4, and TLR-9. Here, we studied if the parasites induce differences in TLR protein expression, cytokine profiles, and whether receptor inhibition is related to parasite infection. METHOD OF STUDY: Placental tissue explants were infected ex vivo with each parasite, TLRs protein expression, cytokine profile and parasite infection were determined by Western blotting, ELISA and qPCR. RESULTS: Trypanosoma cruzi and Toxoplasma gondii infection is related to TLR-2 and TLR-4/TLR-9, respectively. Trypanosoma cruzi elicits an increase in TNF-α, IL-1ß, IL-6, IL-8 and IL-10 cytokine secretion whereas T. gondii only increases the secretion of IL-8. CONCLUSION: The susceptibility of the placenta to each parasite is mediated partially by the innate immune response.


Subject(s)
Chorionic Villi/immunology , Chorionic Villi/parasitology , Cytokines/immunology , Toll-Like Receptors/immunology , Toxoplasma , Trypanosoma cruzi , Animals , Chagas Disease/immunology , Chlorocebus aethiops , DNA, Protozoan , Female , Humans , Parasite Load , Pregnancy , Toxoplasma/genetics , Toxoplasmosis/immunology , Trypanosoma cruzi/genetics , Vero Cells
9.
Emerg Top Life Sci ; 1(6): 573-577, 2017 Dec 22.
Article in English | MEDLINE | ID: mdl-33525837

ABSTRACT

Congenital Chagas disease, caused by Trypanosoma cruzi (T. cruzi), is partially responsible for the increasing globalization of Chagas disease despite its low transmission. During congenital transmission, the parasite reaches the fetus by crossing the placental barrier. However, the success or impairment of congenital transmission of the parasite is the product of a complex interaction between the parasite, the maternal and fetus/newborn immune responses and placental factors. There is other evidence apart from the low congenital transmission rates, which suggests the presence of defense mechanisms against T. cruzi. Thus, the typical amastigote nests (intracellular parasites) cannot be observed in placentas from mothers with chronic Chagas disease nor in human placental chorionic villi explants infected in vitro with the parasite. In the latter, only a few parasite antigens and DNA are identified. Accordingly, other infections of the placenta are not commonly observed. All these evidences suggest that the placenta can mount defense mechanisms against T. cruzi.

10.
J Cell Biochem ; 118(7): 1722-1732, 2017 07.
Article in English | MEDLINE | ID: mdl-27935092

ABSTRACT

FLAP endonucleases (FEN) are involved both in DNA replication and repair by processing DNA intermediaries presenting a nucleotide flap using its phosphodiesterase activity. In spite of these important functions in DNA metabolism, this enzyme was not yet studied in Trypanosomatids. Trypanosoma cruzi, the ethiological agent of Chagas disease, presents two dividing cellular forms (epimastigote and amastigote) and one non-proliferative, infective form (trypomastigote). The parasite survives DNA damage produced by reactive species generated in its hosts. The activity of a T. cruzi FLAP endonuclease (TcFEN1) was determined in the three cellular forms of the parasite using a DNA substrate generated by annealing three different oligonucleotides to form a double-stranded DNA with a 5' flap in the middle. This activity showed optimal pH and temperature similar to other known FENs. The substrate cut by the flap endonuclease activity could be ligated by the parasite generating a repaired DNA product. A DNA flap endonuclease coding sequence found in the T. cruzi genome (TcFEN1) was cloned, inserted in parasite expression vectors and transfected to epimastigotes. The purified native recombinant protein showed DNA flap endonuclease activity. This endonuclease was found located in the parasite nucleus of transfected epimastigotes and its over-expression increased both parasite proliferation and survival to H2 O2 . The presence of a flap endonuclease activity in T. cruzi and its nuclear location are indicative of the participation of this enzyme in DNA processing of flap fragments during DNA replication and repair in this parasite of ancient evolutive origin. J. Cell. Biochem. 118: 1722-1732, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Flap Endonucleases/metabolism , Protozoan Proteins/metabolism , Trypanosoma cruzi/enzymology , Trypanosoma cruzi/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Computational Biology , DNA Repair/drug effects , DNA Repair/genetics , Flap Endonucleases/genetics , Hydrogen Peroxide/pharmacology , Oxidative Stress/drug effects , Protozoan Proteins/genetics , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/genetics
11.
Exp Parasitol ; 173: 9-17, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27939813

ABSTRACT

Congenital transmission of Trypanosoma cruzi (T. cruzi) is partially responsible for the progressive globalization of Chagas disease. During congenital transmission the parasite must cross the placental barrier where the trophoblast, a continuous renewing epithelium, is the first tissue in contact with the parasite. The trophoblast turnover implies cellular proliferation, differentiation and apoptotic cell death. The epithelial turnover is considered part of innate immunity. We previously demonstrated that T. cruzi induces cellular differentiation and apoptosis in this tissue. Here we demonstrate that T. cruzi induces cellular proliferation in a trophoblastic cell line. We analyzed the cellular proliferation in BeWo cells by determining DNA synthesis by BrdU incorporation assays, mitotic index, cell cycle analysis by flow cytometry, as well as quantification of nucleolus organizer regions by histochemistry and expression of the proliferation markers PCNA and Ki67 by Western blotting and/or immunofluorescence. Additionally, we determined the ERK1/2 MAPK pathway activation by the parasite by Western blotting.


Subject(s)
Cell Proliferation , Trophoblasts/cytology , Trophoblasts/parasitology , Trypanosoma cruzi/physiology , Animals , Cell Division , Cell Line, Tumor , DNA/biosynthesis , Flow Cytometry , G2 Phase , Ki-67 Antigen/metabolism , MAP Kinase Signaling System , Mitotic Index , Nucleolus Organizer Region/ultrastructure , Proliferating Cell Nuclear Antigen/metabolism , S Phase , Trophoblasts/metabolism
12.
Microb Pathog ; 99: 123-129, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27554274

ABSTRACT

Congenital Chagas disease, caused by Trypanosoma cruzi, is partially responsible for the progressive globalization of Chagas disease despite of its low transmission rate. The probability of congenital transmission depends on complex interactions between the parasite, the maternal and fetus/newborn immune responses and placental factors, being the latter the least studied one. During transplacental transmission, the parasite must cross the placental barrier where the trophoblast, a continuous renewing epithelium, is the first tissue to have contact with the parasite. Importantly, the epithelial turnover is considered part of the innate immune system since pathogens, prior to cell invasion, must attach to the surface of cells. The trophoblast turnover involves cellular processes such as proliferation, differentiation and apoptotic cell death, all of them are induced by the parasite. In the present review, we analyze the current evidence about the trophoblast epithelial turnover as a local placental innate immune response.


Subject(s)
Chagas Disease/immunology , Immunity, Innate , Placenta/immunology , Placenta/parasitology , Pregnancy Complications, Infectious/immunology , Trophoblasts/immunology , Trypanosoma cruzi/immunology , Apoptosis , Cell Differentiation , Cell Proliferation , Chagas Disease/parasitology , Female , Humans , Pregnancy , Pregnancy Complications, Infectious/parasitology , Trophoblasts/parasitology , Trophoblasts/physiology
13.
PLoS One ; 11(6): e0157270, 2016.
Article in English | MEDLINE | ID: mdl-27284968

ABSTRACT

Trypanosoma cruzi, the etiological agent of Chagas' disease, presents three cellular forms (trypomastigotes, epimastigotes and amastigotes), all of which are submitted to oxidative species in its hosts. However, T. cruzi is able to resist oxidative stress suggesting a high efficiency of its DNA repair machinery.The Base Excision Repair (BER) pathway is one of the main DNA repair mechanisms in other eukaryotes and in T. cruzi as well. DNA glycosylases are enzymes involved in the recognition of oxidative DNA damage and in the removal of oxidized bases, constituting the first step of the BER pathway. Here, we describe the presence and activity of TcNTH1, a nuclear T. cruzi DNA glycosylase. Surprisingly, purified recombinant TcNTH1 does not remove the thymine glycol base, but catalyzes the cleavage of a probe showing an AP site. The same activity was found in epimastigote and trypomastigote homogenates suggesting that the BER pathway is not involved in thymine glycol DNA repair. TcNTH1 DNA-binding properties assayed in silico are in agreement with the absence of a thymine glycol removing function of that parasite enzyme. Over expression of TcNTH1 decrease parasite viability when transfected epimastigotes are submitted to a sustained production of H2O2.Therefore, TcNTH1 is the only known NTH1 orthologous unable to eliminate thymine glycol derivatives but that recognizes and cuts an AP site, most probably by a beta-elimination mechanism. We cannot discard that TcNTH1 presents DNA glycosylase activity on other DNA base lesions. Accordingly, a different DNA repair mechanism should be expected leading to eliminate thymine glycol from oxidized parasite DNA. Furthermore, TcNTH1 may play a role in the AP site recognition and processing.


Subject(s)
Chagas Disease/parasitology , DNA Glycosylases/metabolism , Trypanosoma cruzi/enzymology , Trypanosoma cruzi/physiology , Amino Acid Sequence , Animals , Cell Line , DNA Damage , DNA Glycosylases/chemistry , DNA Glycosylases/genetics , DNA Repair , Gene Expression Regulation , Humans , Models, Molecular , Oxidative Stress , Protein Conformation , Rats , Sequence Alignment , Thymine/analogs & derivatives , Thymine/metabolism , Trypanosoma cruzi/chemistry , Trypanosoma cruzi/genetics
14.
Exp Parasitol ; 168: 9-15, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27328973

ABSTRACT

Congenital Chagas disease is caused by the protozoan parasite Trypanosoma cruzi that must cross the placental barrier during transmission. The trophoblast constitutes the first tissue in contact with the maternal-blood circulating parasite. Importantly, the congenital transmission rates are low, suggesting the presence of local placental defense mechanisms. Cellular proliferation and differentiation as well as apoptotic cell death are induced by the parasite and constitute part of the epithelial turnover of the trophoblast, which has been suggested to be part of those placental defenses. On the other hand, caspase-8 is an essential molecule in the modulation of trophoblast turnover by apoptosis and by epithelial differentiation. As an approach to study whether T. cruzi induced trophoblast turnover and infection is mediated by caspase-8, we infected BeWo cells (a trophoblastic cell line) with the parasite and determined in the infected cells the expression and enzymatic activity of caspase-8, DNA synthesis (as proliferation marker), ß-human chorionic gonadotropin (ß-hCG) (as differentiation marker) and activity of Caspase-3 (as apoptotic death marker). Parasite load in BeWo cells was measured by DNA quantification using qPCR and cell counting. Our results show that T. cruzi induces caspase-8 activity and that its inhibition increases trophoblast cells infection while decreases parasite induced cellular differentiation and apoptotic cell death, but not cellular proliferation. Thus, caspase-8 activity is part of the BeWo trophoblast cell defense mechanisms against T. cruzi infection. Together with our previous results, we suggest that the trophoblast turnover is part of local placental anti-parasite mechanisms.


Subject(s)
Caspase 8/metabolism , Trophoblasts/enzymology , Trophoblasts/parasitology , Trypanosoma cruzi/immunology , Animals , Apoptosis , Caspase 3/metabolism , Caspase 8/immunology , Caspase Inhibitors/pharmacology , Cell Line , Chlorocebus aethiops , Female , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Humans , Trophoblasts/immunology , Vero Cells
15.
Vet Parasitol ; 218: 43-5, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26872926

ABSTRACT

Echinococcus granulosus protoscolex proteins were separated using two-dimensional electrophoresis and then identified using mass spectrometry; we identified 61 proteins, 28 which are newly described of which 4 could be involved in hydatid cyst fertility molecular mechanisms.


Subject(s)
Echinococcus granulosus/genetics , Echinococcus granulosus/metabolism , Helminth Proteins/metabolism , Proteomics , Animals , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation, Developmental , Helminth Proteins/genetics , Helminth Proteins/isolation & purification , Life Cycle Stages
16.
Am J Trop Med Hyg ; 92(5): 887-97, 2015 May.
Article in English | MEDLINE | ID: mdl-25758653

ABSTRACT

Trypanosoma cruzi calreticulin (TcCRT), a 47-kDa chaperone, translocates from the endoplasmic reticulum to the area of flagellum emergence. There, it binds to complement components C1 and mannan-binding lectin (MBL), thus acting as a main virulence factor, and inhibits the classical and lectin pathways. The localization and functions of TcCRT, once the parasite is inside the host cell, are unknown. In parasites infecting murine macrophages, polyclonal anti-TcCRT antibodies detected TcCRT mainly in the parasite nucleus and kinetoplast. However, with a monoclonal antibody (E2G7), the resolution and specificity of the label markedly improved, and TcCRT was detected mainly in the parasite kinetoplast. Gold particles, bound to the respective antibodies, were used as probes in electron microscopy. This organelle may represent a stopover and accumulation site for TcCRT, previous its translocation to the area of flagellum emergence. Finally, early during T. cruzi infection and by unknown mechanisms, an important decrease in the number of MHC-I positive host cells was observed.


Subject(s)
Calreticulin/metabolism , Chagas Disease/parasitology , Macrophages/parasitology , Trypanosoma cruzi/metabolism , Animals , Antibodies, Protozoan/immunology , Antigens, Protozoan/immunology , Calreticulin/immunology , Cell Line , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Complement C1/metabolism , Host-Parasite Interactions , Humans , Macrophages/metabolism , Mannose-Binding Lectin/metabolism , Mice , Models, Biological , Molecular Chaperones/immunology , Molecular Chaperones/metabolism , Organelles/metabolism , Organelles/ultrastructure , Protozoan Proteins/immunology , Protozoan Proteins/metabolism , Rabbits , Recombinant Proteins , Trypanosoma cruzi/immunology , Trypanosoma cruzi/ultrastructure , Virulence Factors/immunology , Virulence Factors/metabolism
17.
J Proteome Res ; 14(4): 1700-15, 2015 Apr 03.
Article in English | MEDLINE | ID: mdl-25748451

ABSTRACT

The 14-3-3 protein family of eukaryotic regulators was studied in Echinococcus granulosus, the causative agent of cystic hydatid disease. These proteins mediate important cellular processes in eukaryotes and are expected to play important roles in parasite biology. Six isoforms of E. granulosus 14-3-3 genes and proteins (Eg14-3-3.1-6) were analyzed, and their phylogenetic relationships were established with bona fide 14-3-3 orthologous proteins from eukaryotic species. Eg14-3-3 isoforms with previous evidence of expression (Eg14-3-3.1-4) in E. granulosus pathogenic larval stage (metacestode) were cloned, and recombinant proteins were used for functional studies. These protein isoforms were detected in different components of E. granulosus metacestode, including interface components with the host. The roles that are played by Eg14-3-3 proteins in parasite biology were inferred from the repertoires of interacting proteins with each isoform, as assessed by gel overlay, cross-linking, and affinity chromatography assays. A total of 95 Eg14-3-3 protein ligands were identified by mass spectrometry. Eg14-3-3 isoforms have shared partners (44 proteins), indicating some overlapping functions; however, they also bind exclusive partners (51 proteins), suggesting Eg14-3-3 functional specialization. These ligand repertoires indicate the involvement of Eg14-3-3 proteins in multiple biochemical pathways in the E. granulosus metacestode and note some degree of isoform specialization.


Subject(s)
14-3-3 Proteins/genetics , 14-3-3 Proteins/metabolism , Echinococcosis/parasitology , Echinococcus granulosus/metabolism , Echinococcus granulosus/pathogenicity , Ligands , Phylogeny , Amino Acid Sequence , Animals , Benzhydryl Compounds , Chromatography, Affinity , Cloning, Molecular , Cluster Analysis , Fluorescent Antibody Technique , Gene Components , Glucosides , Immunoblotting , Larva/metabolism , Larva/pathogenicity , Mass Spectrometry , Molecular Sequence Data , Protein Interaction Mapping , Protein Isoforms/genetics , Protein Isoforms/metabolism
18.
Vet Parasitol ; 205(1-2): 125-33, 2014 Sep 15.
Article in English | MEDLINE | ID: mdl-24962125

ABSTRACT

Hydatidosis is an important zoonotic disease of worldwide distribution, causing important health problems to humans and major economical losses in infected livestock. Echinococcus granulosus, the etiological agent of hydatid disease, induces a humoral immune response in the intermediate host (human and herbivorous) against hydatid cyst antigens. Specifically, IgGs are found in the laminar and germinal layers and inside the lumen of fertile and infertile hydatid cysts. In the germinal layer of infertile cysts IgGs are found in an order of magnitude greater than in the germinal layer of fertile cysts; a fraction of those IgGs are associated with high affinity to germinal layer proteins, suggesting their binding to specific parasite antigens. We have previously shown that those immunoglobulins, bound with high affinity to the germinal layer of hydatid cysts, induce apoptosis leading to cyst infertility. In the present work the presence of IgG1 and IgG2 subclasses in the germinal layer of both fertile and infertile hydatid cysts is reported. IgG1 is the most relevant immunoglobulin subclass present in the germinal layer of infertile cysts and bound with high affinity to that parasite structure. Contrarily, though the IgG2 subclass was also found in the germinal and adventitial layers, those immunoglobulins show low affinity to parasite antigens. We propose that the binding of an IgG1 subclass to parasite antigens present in the germinal layer is involved in the mechanism of cyst infertility.


Subject(s)
Antibodies, Helminth/classification , Cattle Diseases/parasitology , Echinococcosis/veterinary , Echinococcus granulosus/immunology , Immunoglobulin G/blood , Animals , Cattle , Echinococcosis/parasitology , Immunoglobulin G/classification
19.
Acta Trop ; 132: 112-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24462796

ABSTRACT

Nifurtimox (Nfx) and Benznidazole (Bnz) are the only available drugs in use for the treatment of Chagas disease. These drugs are recommended but not fully validated in evidence-based medicine and reports about the differential toxicity of both drugs are controversial. Here, we evaluated the toxic and therapeutic effects of Nfx and Bnz on human placental chorionic villi explants (HPCVE) during ex vivo infection of Trypanosoma cruzi, performing histopathological, histochemical, immunohistochemical as well as immunofluorescence analysis of the tissue. Additionally, we determined the effect of both drugs on parasite load by real time PCR. Bnz prevents the parasite induced tissue damage in ex vivo infected HPCVE compared to Nfx, which is toxic per se. The presence of T. cruzi antigens and DNA in infected explants suggests that these drugs do not impair parasite invasion into the HPCVE. Additionally, our results confirm reports suggesting that Bnz is less toxic than Nfx and support the need for the development of more effective and better-tolerated drugs.


Subject(s)
Antiparasitic Agents/pharmacology , Chorionic Villi/parasitology , Nifurtimox/pharmacology , Nitroimidazoles/pharmacology , Placenta/parasitology , Trypanosoma cruzi/drug effects , Antiparasitic Agents/adverse effects , Female , Histocytochemistry , Humans , Immunohistochemistry , In Vitro Techniques , Microscopy, Fluorescence , Nifurtimox/adverse effects , Nitroimidazoles/adverse effects , Parasite Load , Pregnancy , Real-Time Polymerase Chain Reaction
20.
Parasitology ; 141(5): 682-96, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24476762

ABSTRACT

Chagas disease, endemic in 21 countries across Latin America, kills more people in the region each year than any other parasite-borne disease. Therapeutic options have problems ranging from toxicity, poor efficacy, drug resistance and high cost. Thus, cheaper and less toxic treatments are necessary. From our in-house chemical library of agents against Trypanosoma cruzi the most relevant N-oxide-containing heterocycles were selected for mode of action and type of death studies. Also included in these studies were two active nitrofuranes. Epimastigotes of T. cruzi were used as the biological model in this study. The metabolic profile was studied by 1H NMR in association with the MTT assay. Excreted catabolites data, using 1H NMR spectroscopy, showed that most of the studied N-oxides were capable of decreasing both the release of succinate and acetate shedding, the compounds therefore possibly acting on mitochondria. Only quinoxalines and the nitrofurane Nf1 showed significant mitochondrial dehydrogenase inhibitions, but with different dose-time profiles. In the particular case of quinoxaline Qx2 the glucose uptake study revealed that the integrity of some pathways into the glycosome could be affected. Optic, fluorescence (TUNEL and propidium iodide) and transmission electron microscopy (TEM) were employed for type of death studies. These studies were complemented with 1H NMR to visualize mobile lipids. At low concentrations none of the selected compounds showed a positive TUNEL assay. However, both quinoxalines, one furoxan and one benzofuroxan showed a necrotic effect at high concentrations. Curiously, one furoxan, Fx1, one benzofuroxan, Bfx1, and one nitrofurane, Nf1, caused a particular phenotype, with a big cytoplasmatic vacuole being observed while the parasite was still alive. Studies of TEM and employing a protease inhibitor (3-methyladenine) suggested an autophagic phenotype for Bfx1 and Nf1 and a 'BigEye' phenotype for Fx1.


Subject(s)
Chagas Disease/parasitology , Cyclic N-Oxides/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Autophagy/drug effects , Cell Death/drug effects , Cyclic N-Oxides/chemistry , Humans , Microscopy, Electron, Transmission , Necrosis , Phenotype , Trypanocidal Agents/chemistry , Trypanosoma cruzi/physiology , Trypanosoma cruzi/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...